[ORGANIZATION]
Petrelintide
Featured in 2 tracked stories · first seen
Situations
Eli Lilly EloraTZP obesity drug clinical trials
3 clusters · 19 sources · last updated
Latest: Eli Lilly weight-loss drug combination shows significant results
Eli Lilly has reported results from Phase 2b clinical trials for EloraTZP, a combination therapy involving eloralinantide and tirzepatide designed to treat obesity and type 2 diabetes. Data presented at the European Ass
Clinical developments in obesity and diabetes medications
2 clusters · 12 sources · last updated
Latest: Zealand Pharma reports positive Phase 2 results for obesity drug petrelintide
Pharmaceutical developments regarding experimental treatments for obesity and type 2 diabetes have shown positive results in Phase II clinical trials. In late September 2026, Roche and Genentech reported successful Phas